Important Announcement

X

ChemIDplus is moving to PubChem in December 2022.
Please see the NLM Technical Bulletin article for more information.

Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Stanozolol [USAN:USP:INN:BAN:JAN]
RN: 10418-03-8
UNII: 4R1VB9P8V3
InChIKey: LKAJKIOFIWVMDJ-IYRCEVNGSA-N

Notes

  • A synthetic steroid that has anabolic and androgenic properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1194)
  • Tautomeric form of Stanozolol.

Molecular Formula

  • C21-H32-N2-O

Molecular Weight

  • 328.4968
 

Classification Codes

Classification Codes

  • Anabolic Agents
  • Androgen
  • Androgens
  • Hormone
  • Hormones
  • Hormones, Hormone Substitutes, and Hormone Antagonists
  • Human Data
  • Reproductive Effect

Superlist Classification Code

  • DEA Schedule III
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Stanozolol
  • Stanozolol (1'H form)
  • Stanozolol (2'H form)
  • Stanozolol [USAN:USP:INN:BAN:JAN]

MeSH Heading

  • Stanozolol

Synonyms

  • 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-Hexadecahydro-1,10a,12a-trimethylcyclopenta(7,8)-phenanthro(2,3-c)pyrazol-1-ol
  • 17-beta-Hydroxy-17-alpha-methylandrostano(3,2-c)pyrazole
  • 17-Methyl-2'H-5alpha-androst-2-eno(3,2-c)pyrazol-17beta-ol
  • 17-Methyl-5alpha-androstano(3,2-c)pyrazol-17beta-ol
  • 17-Methyl-pyrazolo(4',3':2,3)-5alpha-androstan-17beta-ol
  • 17-Methylpyrazolo(4',3':2,3)-5alpha-androstan-17beta-ol
  • 17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole
  • 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole
  • 17beta-Hydroxy-17alpha-methyl-androstano(3,2-c)pyrazole
  • 2'H-5alpha-Androst-2-eno(3,2-c)pyrazol-17beta-ol, 17-methyl-
  • 2'H-Androst-2-eno(3,2-c)pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
  • 2,3-(4',3'-Pyrazolo)-5alpha-androstan-17beta-ol, 17-methyl-
  • Anabol
  • Androstanazol
  • Androstanazole
  • Androstanazole (VAN)
  • EINECS 233-894-8
  • Estanozolol
  • Estanozolol [INN-Spanish]
  • Estazol
  • HSDB 3185
  • NSC 233046
  • NSC 43193
  • Stanazolol
  • Stanozolo
  • Stanozolo [DCIT]
  • Stanozolol
  • Stanozololum
  • Stanozololum [INN-Latin]
  • Stromba
  • Strombaject
  • Tevabolin
  • UNII-4R1VB9P8V3
  • WIN 14833
  • Winstroid
  • Winstrol
  • Winstrol Depot
  • Winstrol V

Systematic Names

  • 1'H-Androstano(3,2-c)pyrazol-17-ol, 17-methyl-, (5-alpha,17-beta)-
  • 2'H-Androst-2-eno(3,2-c)pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
  • Cyclopenta(7,8)phenanthro(2,3-c)pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
  • Cyclopenta(7,8)phenanthro(2,3-c)pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
  • Stanozolol

Superlist Names

  • 17alpha-Methyl-17beta-hydroxy-5alpha-androst-2-eno(3,2-c)-pyrazole
  • DEA No. 4000
  • Stanozolol
  • Winstrol
  • Winstrol-V

Registry Numbers

CAS Registry Number

  • 10418-03-8

FDA UNII

  • 4R1VB9P8V3

Other Registry Numbers

  • 17966-55-1
  • 302-96-5
  • 69353-49-7
  • 875293-72-4

Related Registry Number

  • 302-96-5 (Alternate Registry Number)

System Generated Number

  • 0010418038

Structure Descriptors

InChI

InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1

InChIKey

LKAJKIOFIWVMDJ-IYRCEVNGSA-N

Smiles

C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4Cc5[nH]ncc5C[C@]4(C)[C@H]3CC[C@]12C

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo intramuscular 16mg/kg/31D-I (16mg/kg) LIVER: "JAUNDICE, CHOLESTATIC"

KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"

LIVER: LIVER FUNCTION TESTS IMPAIRED		 Canadian Medical Association Journal. Vol. 151, Pg. 791, 1994.
man TDLo oral 4285mg/kg/30D (4285mg/kg) LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED" British Medical Journal. Vol. 294, Pg. 612, 1987.
mouse LD50 oral > 4gm/kg (4000mg/kg)   Drugs in Japan Vol. 6, Pg. 375, 1982.
women TDLo oral 24mg/kg/17W-I (24mg/kg) LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED" British Medical Journal. Vol. 294, Pg. 612, 1987.